Law & Arbitration · Industries
Pharmaceutical Lawyers
Life sciences, licensed and protected with precision.
Handle’s pharmaceutical lawyers act for manufacturers, distributors, research organisations and healthcare investors on MOHAP and DOH registration, clinical and supply agreements, IP protection and disputes — keeping products compliant and partnerships enforceable.
When this is needed
Pharmaceutical Lawyers in the UAE: where the mandate begins.
- A product must be registered, licensed or renewed with MOHAP or the DOH.
- A clinical trial, manufacturing or distribution agreement must allocate liability and IP clearly.
- A recall, inspection or regulatory investigation is under way.
- A distributor, licensing or research partnership dispute threatens supply or IP.
Matters Handle leads
Pharmaceutical legal mandates.
Four mandate types. One compliant, protected product portfolio.
Drug Registration & Licensing
MOHAP and DOH approvals, documentation and renewals.
Clinical & Supply Agreements
Clinical trial, manufacturing, distribution and testing contracts.
IP & Data Protection
Patents, data exclusivity and licensing terms.
Pharma Disputes & Arbitration
Distribution, IP, liability and regulatory disputes.
The scope
Pharmaceutical Lawyers — scope, made explicit.
A focused, premium mandate — with the product, its approvals and its IP at the center.
Regulatory Approvals
Registration and licensing managed with the authorities.
Contract Structuring
Clinical, supply and distribution terms drafted to hold.
Recall & Liability
Recall frameworks and liability defence prepared.
Pricing & Procurement
Pricing controls and government procurement navigated.
Enforcement
Awards recognised and executed internationally.
The mandate
Pharmaceutical law with regulatory precision.
In pharmaceuticals, a product’s value depends on its approvals and its IP. Handle’s pharmaceutical lawyers manage registration and structure clinical, supply and licensing agreements so both stay protected.
When regulators inspect or partners dispute, the same team leads the response and protects continuity of supply.
What the mandate delivers
- Licensing and regulatory compliance
- Clinical trial and research governance
- IP and patent protection
- Manufacturing and supply contracts
- Recall and product liability advisory
- Pharma arbitration and enforcement
How the work runs
Four disciplines. One compliant product portfolio.
Every pharmaceutical mandate is run with regulatory, contractual, IP and dispute control.
01
Regulatory Compliance
MOHAP and DOH requirements met and maintained.
02
Commercial Contracts
Clinical, supply and distribution terms structured for control.
03
IP Protection
Patents and data exclusivity secured.
04
Dispute Resolution
Supplier, licensing and liability disputes resolved.
The Handle model
Practice-led. Never fragmented.
The matter may begin in one sector — it stays connected to strategy, capital and law.
Strategy & Operations
The work stays connected to market position, operating model, performance and execution governance.
M&A & Capital
The work stays aware of capital readiness, investor review, transaction logic and deployment discipline where relevant.
Legal & Regulatory
The work stays protected through structure, rights, governance, enforceability and regulatory or dispute readiness.
Why Handle
Scientific markets. Regulatory execution.
Handle’s pharmaceutical lawyers combine regulatory and IP knowledge with dispute capability — and connect every mandate to the investment and market strategy behind the portfolio.
- UAE and international pharmaceutical law experience
- Product licensing and healthcare compliance
- Regulatory and supplier dispute record
- Pharma arbitration and IP protection
- Cross-border GCC and EU transactions
- Partner-led mandates with institutional discipline
Good litigation is disciplined project management. Clear filings, clean evidence, and a hearing plan that your board understands. That is how outcomes travel from courtroom to cash.
Hamda Al FalasiPartner, Law & Arbitration
Engagement paths
Where this work typically begins.
Growth & Expansion
When the asset must scale capacity, geography, capital, partnerships or market share.
Turnaround
When the asset must reset structure, capital, law, governance and operations under pressure.
Coverage
Pharmaceutical lawyers across UAE regulators and forums.
Handle’s pharmaceutical lawyers work with MOHAP and the DOH, and act before the UAE courts, DIFC and ADGM Courts and arbitral tribunals.
Forums · Courts & arbitration
Industry practices · Law & Arbitration
Real Estate LawyersInfrastructure & Construction LawyersFinancial Services LawyersEnergy LawyersHealthcare LawyersManufacturing & Industrial LawyersConsumer & Retail LawyersTechnology LawyersPublic Sector LawyersPrivate Enterprises & Family Offices LawyersAviation LawyersMaritime LawyersEcommerce LawyersFashion LawyersFood & Beverage LawyersAutomotive LawyersEducation LawyersSports LawyersTravel & Hospitality LawyersEntertainment LawyersNon Profit & NGO LawyersLuxury LawyersCrypto LawyersInsurance LawyersFintech LawyersSaaS LawyersYachting LawyersHotels & Resorts LawyersReal Estate Arbitration Lawyers
Questions, answered
Pharmaceutical Lawyers — questions, answered.
How Handle’s pharmaceutical lawyers keep products compliant and partnerships protected.
What do Handle’s pharmaceutical lawyers do?
They advise on licensing, manufacturing, distribution and compliance.
Does Handle manage regulatory approvals?
Yes. MOHAP and DOH registration and product licensing are managed.
Can Handle act in clinical trial disputes?
Yes. Agreements are enforced and liability managed in clinical partnerships.
Does Handle draft distribution contracts?
Yes. Contracts are built to meet regulatory and commercial requirements.
Can Handle manage IP and patent disputes?
Yes. Pharmaceutical innovations are protected under UAE and international frameworks.
Does Handle handle inspections and investigations?
Yes. Compliance audits and remediation actions are managed.
Can Handle support cross-border pharma transactions?
Yes. Regional partnerships and acquisitions in GCC and EU markets are handled.
Does Handle advise on product liability and recalls?
Yes. Recall frameworks and liability defence are prepared.
Does Handle advise on pricing and government procurement?
Yes. UAE pricing controls and procurement frameworks are navigated.
What differentiates Handle’s pharmaceutical practice?
Regulatory execution in complex scientific markets.
Insights
Perspectives from live mandates.
Partner-led analysis on law, capital and strategy, shaped by boardroom realities across the UAE and the GCC.
Toku Launches UAE Unit as Talabat Scales Contact-Centre Rollout Across Eight MENA Markets
Toku Launches UAE Unit as Talabat Scales Contact-Centre Rollout Across Eight MENA Markets
Majid Al Futtaim Posts Record H1 EBITDA of AED 2.5 Billion as Growth Momentum Builds
Majid Al Futtaim Posts Record H1 EBITDA of AED 2.5 Billion as Growth Momentum Builds
UAE-Germany Investment Push: Al Jaber Calls for New Council to Unlock Long-Term Capital and Tech Growth
UAE-Germany Investment Push: Al Jaber Calls for New Council to Unlock Long-Term Capital and Tech Growth
Work with Handle
Work with Handle’s Pharmaceutical lawyers — kept connected to the whole Handle model.
When approvals, IP and supply must hold.
Request an initial review
When a pharmaceutical position must be protected.
Set out the matter. A partner reviews it and responds with a defined route, legal strategy and accountable lead.
- Partner-level review of every request
- Strict confidentiality and privilege from first contact
- One accountable partner from review to execution
